Baylor College of Medicine receives additional $14 million in state cancer funding
Researchers from the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine in Houston have received an additional $14 million in grants from the Cancer Prevention and Research Institute of Texas.
BCM has received more than $87 million from the CPRIT since the program began awarding grants to Texas researchers in January 2010.
Two of the new awards will support recruitment of young and established researchers.
BCM received a $2 million award to recruit a first-time faculty member, as well as a $4.5 million award to recruit a rising star in cancer research.
Dr. Jianming Xu, professor of molecular and cellular biology at BCM, received a $900,000 individual investigator award to study an incurable form of prostate cancer. Read a summary of the award.
Dr. Donald Parsons, assistant professor of hematology oncology at BCM and a member of the Texas Children's Cancer Center, received a $1,478,447, multi-investigator award to study two types of sarcoma that commonly strike children and young adults. Read a summary of the award.
Collaborative BCM awards
Dr. Chad Creighton, Dr. Kenneth Scott and Professor Mary E. Dickinson will collaborate on a multi-investigator award to study lung cancer that spreads to other parts of the body. Together, the team was awarded more than $1.6 million for the project. Creighton is a professor of medicine and a biostatistician, Scott is an assistant professor of molecular and human genetics and Dickinson an associate professor of molecular physiology, all of BCM. Read a summary of the award.
Dr. Milton Finegold, Dr. Dolores Lopez-Terrada and Dr. Donald Parsons will collaborate on a multi-investigator award that focuses on pediatric liver cancer, one of the less common types of childhood cancer. Together, the team was awarded more than $180,000 for the project. Read a summary of the award. All of BCM, Finegold is a professor of pathology and Lopez-Terrada an associate professor of pathology.
Dr. Suzanne Fuqua, Dr. Bert O'Malley and Dr. Jianming Xu, will collaborate on a multi-investigator award to study new ways to personalize treatment for breast and lung cancers. Together, the team was awarded more than $3.5 million for the project. Read a summary of the award. All of BCM, Fuqua is a professor in the Lester and Sue Smith Breast Center and O'Malley is chair of molecular and cellular biology as well as associate director of basic science in the Duncan Cancer Center.
Additionally, BCM will be involved in a collaborative grant with The University of Texas Southwestern Medical Center at Dallas and the University of Texas Health Science Center at San Antonio that will seek to identify and track genetic changes, as they occur in real time, in sarcoma patients across Texas.
In this latest round of CPRIT funding, BCM received the largest total amount of funding awarded to a Houston institution.